WVU student discovers long-awaited mystery fungus sought by LSD’s inventor
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Aug-2025 10:10 ET (15-Aug-2025 14:10 GMT/UTC)
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025 – propelling a new era of precision medicine in breast cancer.
In a new multi-center study led by Boston University Chobanian & Avedisian School of Medicine, researchers have found that aggressive surgery in patients with advanced gallbladder cancer (T3/T4) can lead to high complication and mortality rates, especially in those in the T4 patients that invade adjacents organs of the disease.
A new study by researchers from Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, has found that more than 110,000 firearm suicides could potentially have been prevented (from 2010-2019) had each state implemented the most impactful firearm related law in that state, specifically including child access prevention laws and concealed carry permitting policies.